Literature DB >> 22628388

Autosomal dominant congenital spinal muscular atrophy: a true form of spinal muscular atrophy caused by early loss of anterior horn cells.

Emily C Oates1, Stephen Reddel, Michael L Rodriguez, Luke C Gandolfo, Melanie Bahlo, Simon H Hawke, Shireen R Lamandé, Nigel F Clarke, Kathryn N North.   

Abstract

Autosomal dominant congenital spinal muscular atrophy is characterized by predominantly lower limb weakness and wasting, and congenital or early-onset contractures of the hip, knee and ankle. Mutations in TRPV4, encoding a cation channel, have recently been identified in one large dominant congenital spinal muscular atrophy kindred, but the genetic basis of dominant congenital spinal muscular atrophy in many families remains unknown. It has been hypothesized that differences in the timing and site of anterior horn cell loss in the central nervous system account for the variations in clinical phenotype between different forms of spinal muscular atrophy, but there has been a lack of neuropathological data to support this concept in dominant congenital spinal muscular atrophy. We report clinical, electrophysiology, muscle magnetic resonance imaging and histopathology findings in a four generation family with typical dominant congenital spinal muscular atrophy features, without mutations in TRPV4, and in whom linkage to other known dominant neuropathy and spinal muscular atrophy genes has been excluded. The autopsy findings in the proband, who died at 14 months of age from an unrelated illness, provided a rare opportunity to study the neuropathological basis of dominant congenital spinal muscular atrophy. There was a reduction in anterior horn cell number in the lumbar and, to a lesser degree, the cervical spinal cord, and atrophy of the ventral nerve roots at these levels, in the absence of additional peripheral nerve pathology or abnormalities elsewhere along the neuraxis. Despite the young age of the child at the time of autopsy, there was no pathological evidence of ongoing loss or degeneration of anterior horn cells suggesting that anterior horn cell loss in dominant congenital spinal muscular atrophy occurs in early life, and is largely complete by the end of infancy. These findings confirm that dominant congenital spinal muscular atrophy is a true form of spinal muscular atrophy caused by a loss of anterior horn cells localized to lumbar and cervical regions early in development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628388     DOI: 10.1093/brain/aws108

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  8 in total

1.  Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1.

Authors:  Alleene V Strickland; Maria Schabhüttl; Hans Offenbacher; Matthis Synofzik; Natalie S Hauser; Michaela Brunner-Krainz; Ursula Gruber-Sedlmayr; Steven A Moore; Reinhard Windhager; Benjamin Bender; Matthew Harms; Stephan Klebe; Peter Young; Marina Kennerson; Avencia Sanchez Mejias Garcia; Michael A Gonzalez; Stephan Züchner; Rebecca Schule; Michael E Shy; Michaela Auer-Grumbach
Journal:  J Neurol       Date:  2015-06-24       Impact factor: 4.849

2.  Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.

Authors:  Alexander M Rossor; Emily C Oates; Hannah K Salter; Yang Liu; Sinead M Murphy; Rebecca Schule; Michael A Gonzalez; Mariacristina Scoto; Rahul Phadke; Caroline A Sewry; Henry Houlden; Albena Jordanova; Iyailo Tournev; Teodora Chamova; Ivan Litvinenko; Stephan Zuchner; David N Herrmann; Julian Blake; Janet E Sowden; Gyuda Acsadi; Michael L Rodriguez; Manoj P Menezes; Nigel F Clarke; Michaela Auer Grumbach; Simon L Bullock; Francesco Muntoni; Mary M Reilly; Kathryn N North
Journal:  Brain       Date:  2014-12-14       Impact factor: 13.501

3.  Phenotypic variability of TRPV4 related neuropathies.

Authors:  Teresinha Evangelista; Boglarka Bansagi; Angela Pyle; Helen Griffin; Konstantinos Douroudis; Tuomo Polvikoski; Thalia Antoniadi; Kate Bushby; Volker Straub; Patrick F Chinnery; Hanns Lochmüller; Rita Horvath
Journal:  Neuromuscul Disord       Date:  2015-03-18       Impact factor: 4.296

4.  In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis.

Authors:  Daniel C Koboldt; Rama D Kastury; Megan A Waldrop; Benjamin J Kelly; Theresa Mihalic Mosher; Heather McLaughlin; Don Corsmeier; Jonathan L Slaughter; Kevin M Flanigan; Kim L McBride; Lakshmi Mehta; Richard K Wilson; Peter White
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-10-01

5.  Generalized Hypotonia Revealing Spinal Muscular Atrophy Type 2: The First Case Reported From the Dominican Republic and a Review of the Literature.

Authors:  Rubén Blanco; Jessie Pichardo; Hassan Abdullah
Journal:  Cureus       Date:  2020-11-12

Review 6.  Dominant spinal muscular atrophy is caused by mutations in BICD2, an important golgin protein.

Authors:  Lilian A Martinez-Carrera; Brunhilde Wirth
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

7.  Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy.

Authors:  Alexander M Rossor; James N Sleigh; Michael Groves; Francesco Muntoni; Mary M Reilly; Casper C Hoogenraad; Giampietro Schiavo
Journal:  Acta Neuropathol Commun       Date:  2020-03-17       Impact factor: 7.801

8.  Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.

Authors:  Emily C Oates; Alexander M Rossor; Majid Hafezparast; Michael Gonzalez; Fiorella Speziani; Daniel G MacArthur; Monkol Lek; Ellen Cottenie; Mariacristina Scoto; A Reghan Foley; Matthew Hurles; Henry Houlden; Linda Greensmith; Michaela Auer-Grumbach; Thomas R Pieber; Tim M Strom; Rebecca Schule; David N Herrmann; Janet E Sowden; Gyula Acsadi; Manoj P Menezes; Nigel F Clarke; Stephan Züchner; Francesco Muntoni; Kathryn N North; Mary M Reilly
Journal:  Am J Hum Genet       Date:  2013-05-09       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.